Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Other Non-Current Liabilities (2020 - 2025)

Biofrontera has reported Other Non-Current Liabilities over the past 6 years, most recently at $351000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $351000.0 for Q4 2025, down 71.92% from a year ago — trailing twelve months through Dec 2025 was $351000.0 (down 71.92% YoY), and the annual figure for FY2025 was $351000.0, down 71.92%.
  • Other Non-Current Liabilities for Q4 2025 was $351000.0 at Biofrontera, down from $833000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BFRIW hit a ceiling of $11.7 million in Q1 2024 and a floor of $21000.0 in Q4 2022.
  • Median Other Non-Current Liabilities over the past 5 years was $1.5 million (2023), compared with a mean of $3.3 million.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 99.63% in 2022 and later skyrocketed 48779.17% in 2024.
  • Biofrontera's Other Non-Current Liabilities stood at $5.6 million in 2021, then crashed by 99.63% to $21000.0 in 2022, then skyrocketed by 19947.62% to $4.2 million in 2023, then plummeted by 70.31% to $1.2 million in 2024, then crashed by 71.92% to $351000.0 in 2025.
  • The last three reported values for Other Non-Current Liabilities were $351000.0 (Q4 2025), $833000.0 (Q3 2025), and $548000.0 (Q2 2025) per Business Quant data.